HLA-B anticorps (FITC)

N° du produit ABIN201048

Cet anticorps anti-HLA-B est un anticorps Souris Monoclonal détectant HLA-B dans FACS. Adapté pour Humain et Singe.

Aperçu rapide pour HLA-B anticorps (FITC) (ABIN201048)

Antigène: HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))

Reactivité: Humain, Singe

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp HLA-B est conjugé à/à la FITC

Application: Flow Cytometry (FACS)

Détail du produit anti-HLA-B anticorps (FITC)

Specificité: Recognizes the human HLA-B7 antigen. Does not cross-react with HLA-B27 or other related antigens. It can be used to distinguish true HLA-B27 positives from false HLA-B27 positives (i. e. HLA-B7 positive) in the investigation of diseases such as ankylosing spondylitis and anterior uveitis. Species cross-reactivity: Cynomolgus monkey.

Purification: Protein G purified

Immunogène: Papain solubilized HLA-B7 antigen.

Type of Immunogen: Purified protein

Isotype: IgG1

Information d'application

Indications d'application: Approved: Flo

Usage: Suitable for use in Flow Cytometry. Flow Cytometry: Neat-1:10. Use 10 μL to label 1x1 x10⁶ or 100 μL whole blood. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.2, 1 % BSA, 0.1 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.

Détails sur HLA-B

Antigène: HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))

Autre désignation: HLA-B

Sujet: Name/Gene ID: HLA-B

Synonyms: HLA-B, HLAB, MHC Class I HLA heavy chain, Leukocyte antigen class I-B, SPDA1

ID gène: 3106

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response